Viva Biotech Holdings (FRA:VB0)
Germany flag Germany · Delayed Price · Currency is EUR
0.2520
+0.0080 (3.28%)
Last updated: Feb 23, 2026, 8:04 AM CET

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Viva Bioinnovator
18.09M30.61M---
Viva Bioinnovator Growth
-40.90%----
Drug Discovery Services
821.31M866.76M895.06M740.47M438.81M
Drug Discovery Services Growth
-5.24%-3.16%20.88%68.75%35.83%
Contract Development Manufacture Organisation (CDMO) and Commercialisation Services
1.18B1.31B1.48B1.36B258.15M
Contract Development Manufacture Organisation (CDMO) and Commercialisation Services Growth
-10.30%-11.44%8.87%428.22%-
Elimination
-32.09M-56.54M---
Total
1.99B2.16B2.38B2.10B696.96M
Total Growth
-7.84%-9.42%13.10%201.90%115.74%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States of America (USA)
795.83M812.79M915.82M646.52M396.93M
United States of America (USA) Growth
-2.09%-11.25%41.65%62.88%62.95%
Europe
623.34M589.56M508.47M590.23M127.48M
Europe Growth
5.73%15.95%-13.85%363.00%6974.31%
Chinese Mainland
267.23M323.67M382.38M376.74M116.25M
Chinese Mainland Growth
-17.44%-15.35%1.50%224.08%-
Other Asia countries and regions out of Chinese Mainland
193.53M291.39M392.80M330.08M34.90M
Other Asia countries and regions out of Chinese Mainland Growth
-33.59%-25.82%19.00%845.69%-
Africa
45.27M45.03M64.55M74.18M14.19M
Africa Growth
0.53%-30.24%-12.98%422.92%-
Others
61.47M93.14M115.62M86.34M7.22M
Others Growth
-34.00%-19.44%33.91%1096.60%126.46%
Total
1.99B2.16B2.38B2.10B696.96M
Total Growth
-7.84%-9.42%13.10%201.90%115.74%
Source: S&P Global Market Intelligence.